Cargando…
A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis
BACKGROUND: Pemphigus vulgaris (PV) is a kind of IgG-mediated autoimmune blistering disease (AIBD) that is characterized by loss of keratinocyte adhesion in the epithelium of mucous membranes or skin. Recently, pemphigus vulgaris was thought to be associated with classical T helper 2 (T(H2))-type cy...
Autores principales: | Chen, Siji, Zhan, Shaowei, Hua, Chunting, Tang, Yi, Cheng, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863860/ https://www.ncbi.nlm.nih.gov/pubmed/35222408 http://dx.doi.org/10.3389/fimmu.2022.825796 |
Ejemplares similares
-
Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023) -
Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
por: Moore, Angela Y., et al.
Publicado: (2022) -
Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report
por: Khaddour, Hiba Hasan, et al.
Publicado: (2020) -
The complicated use of dupilumab in the treatment of atypical generalized pemphigus erythematosus: A report of two cases
por: Chen, Jie, et al.
Publicado: (2023) -
Mycobacterium tuberculosis and pemphigus vulgaris
por: Osipowicz, Katarzyna, et al.
Publicado: (2018)